We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$259B
AUM Growth
+$31.2B
Cap. Flow
+$19.7B
Cap. Flow %
7.63%
Top 10 Hldgs %
24.01%
Holding
10,422
New
1,312
Increased
3,605
Reduced
3,645
Closed
1,693

Sector Composition

Rank Sector Weight
1 Technology 2.38%
2 Consumer Discretionary 1.42%
3 Communication Services 1.04%
4 Healthcare 0.74%
5 Financials 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CASC
8426
DELISTED
Cascadian Therapeutics, Inc.
CASC
$70K ﹤0.01%
+17,112
New +$65.5K
AMSC icon
8427
PUT
American Superconductor
AMSC
$1.43B
$69K ﹤0.01%
15,300
+5,200
+51% +$20.2K
PIXY
8428
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
0
DMK
8429
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$69K ﹤0.01%
189
-2,888
-94% -$1.02M
STON
8430
CALL
DELISTED
StoneMor Inc.
STON
$69K ﹤0.01%
10,600
-19,600
-65% -$136K
PRKR
8431
DELISTED
Parkervision Inc
PRKR
$69K ﹤0.01%
43,896
+30,077
+218% +$54.7K
AGRX
8432
DELISTED
Agile Therapeutics
AGRX
$68K ﹤0.01%
8
-19
-70% -$146K
ONTXW
8433
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$68K ﹤0.01%
173,112
VLYWW
8434
DELISTED
Valley National Bancorp Warrants (expiring November 14, 2018)
VLYWW
$68K ﹤0.01%
358,242
RPRX
8435
CALL
DELISTED
Repros Therapeutics Inc.
RPRX
$68K ﹤0.01%
212,100
-67,400
-24% -$23.6K
LABD icon
8436
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$59M
$67K ﹤0.01%
7
-110
-94% -$1.33M
OCUL icon
8437
Ocular Therapeutix
OCUL
$2.37B
$67K ﹤0.01%
10,797
-48,180
-82% -$310K
CMRX
8438
PUT
DELISTED
Chimerix, Inc.
CMRX
$67K ﹤0.01%
12,700
-22,700
-64% -$112K
GCAP
8439
CALL
DELISTED
Gain Capital Holdings, Inc.
GCAP
$67K ﹤0.01%
+10,500
New +$68.4K
ACHN
8440
DELISTED
Achillion Pharmaceuticals
ACHN
$67K ﹤0.01%
14,838
-23,711
-62% -$105K
IMUX icon
8441
PUT
Immunic
IMUX
$225M
$66K ﹤0.01%
+33
New +$43.1K
MARK
8442
DELISTED
Remark Holdings, Inc.
MARK
$66K ﹤0.01%
+1,749
New +$52.7K
NM
8443
PUT
DELISTED
Navios Maritime Holdings Inc.
NM
$66K ﹤0.01%
3,930
+480
+14% +$6.79K
ENT
8444
PUT
DELISTED
Global Eagle Entertainment Inc.
ENT
$66K ﹤0.01%
772
+124
+19% +$9.71K
ECYT
8445
DELISTED
Endocyte, Inc. Common Stock
ECYT
$66K ﹤0.01%
46,816
-86,590
-65% -$121K
GNRT
8446
PUT
DELISTED
Gener8 Maritime, Inc.
GNRT
$66K ﹤0.01%
+14,700
New +$72.8K
CXRX
8447
PUT
DELISTED
Concordia International Corp. Common Stock
CXRX
$66K ﹤0.01%
55,800
-2,100
-4% -$2.87K
GGB icon
8448
PUT
Gerdau
GGB
$8.75B
$65K ﹤0.01%
23,940
-213,948
-90% -$601K
NGVC icon
8449
PUT
Vitamin Cottage Natural Grocers
NGVC
$642M
$65K ﹤0.01%
11,600
-8,100
-41% -$54.2K
AGTC
8450
DELISTED
Applied Genetic Technologies Corporation
AGTC
$65K ﹤0.01%
16,529
-61,432
-79% -$282K

Similar funds

Jeff Yass's Q3 2017 Portfolio in Review

As of Q3 2017, Jeff Yass held 10,422 positions worth $259B, up 14% from $228B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jeff Yass deployed $19.7B of net new capital in Q3 2017, opening 1,312 new positions and adding to 3,605 existing holdings. Its largest new stake was JPMorgan Chase: 794,224 shares worth $75.9M.

By sector, the portfolio is most concentrated in Technology at 2.4% of assets, up from 2% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $474M trimmed.

  • Jeff Yass's largest Q3 2017 buy was JPMorgan Chase: 794,224 shares worth $75.9M.
  • Jeff Yass added most to Apple in Q3 2017, an estimated $1.31B increase.
  • Jeff Yass's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $474M.
  • Jeff Yass fully exited iShares 20+ Year Treasury Bond ETF in Q3 2017, selling an estimated $69.3M.
  • Jeff Yass's ten largest holdings make up 24% of its $259B portfolio in Q3 2017.
  • Jeff Yass opened 1,312 new positions and closed 1,693 in Q3 2017.
  • Jeff Yass's portfolio value rose 14% quarter-over-quarter to $259B.

Based on Susquehanna International Group's 13F filing for Q3 2017, filed 14 Nov 2017.